Literature DB >> 11569368

[Customary use of compression stockings for prevention of thrombosis in medical intensive care units in Germany].

W Müllges1, E Steinke, G Moldenhauer, N Berens.   

Abstract

BACKGROUND: Stockings for thrombosis prophylaxis (MTS) are generally advised for all immobilized patients by the German Societies of Surgery, Orthopedics, and Phlebology. In critical care patients, the indication is unclear and many questions are left unanswered, especially if combined with heparins for prophylaxis of thromboembolism. We evaluated the customary use of MTS in critical care patients.
METHODS: A multiple choice questionnaire was sent to the nursing staff of 324 randomly selected German non-surgical ICUs. The answers of 144 units (44.4%) could be evaluated, 15 of which were special neurology, 88 special internal medicine, 41 mixed.
RESULTS: Each 8th ICU principally avoids MTS, each 19th ICU principally provides all patients with MTS. Of those who use special indications, the degree of immobilisation plays an indecisive role with 50% for and 50% against MTS. In particular, coma serves as a contraindication. Effective anticoagulation excludes the need for MTS in half of the ICUs. Polyneuropathies and dysesthesias are the far most noticed arguments against MTS.
CONCLUSIONS: There seems to be an uncertainty about the indication of MTS for non-surgical critical ill patients. With respect to available guidelines, a decision in principle for MTS should be made. However, in the individual patient with relative contraindications and progressively effective anticoagulation, MTS may be dispended relatively liberally.

Entities:  

Mesh:

Year:  2001        PMID: 11569368     DOI: 10.1055/s-2001-16312

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

Review 1.  [Graduated compression stockings in surgery -- optional or obligatory?].

Authors:  Gabriele Meyer; R Gellert; G Schlömer; I Mühlhauser
Journal:  Chirurg       Date:  2003-11-12       Impact factor: 0.955

Review 2.  [Venous thromboembolism prophylaxis].

Authors:  B Dohmen; W Gogarten; R Kuhlen; R Rossaint
Journal:  Anaesthesist       Date:  2004-07       Impact factor: 1.041

3.  Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial.

Authors:  Yaseen M Arabi; Sami Alsolamy; Abdulaziz Al-Dawood; Awad Al-Omari; Fahad Al-Hameed; Karen E A Burns; Mohammed Almaani; Hani Lababidi; Ali Al Bshabshe; Sangeeta Mehta; Abdulsalam M Al-Aithan; Yasser Mandourah; Ghaleb Almekhlafi; Simon Finfer; Sheryl Ann I Abdukahil; Lara Y Afesh; Maamoun Dbsawy; Musharaf Sadat
Journal:  Trials       Date:  2016-08-03       Impact factor: 2.279

4.  [Prevention of thromboembolism in German intensive care units : Results of a nationwide survey].

Authors:  P Hilbert; P Teumer; R Stuttmann
Journal:  Anaesthesist       Date:  2008-03       Impact factor: 1.041

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.